Cargando…

Triptolide reverses the Taxol resistance of lung adenocarcinoma by inhibiting the NF-κB signaling pathway and the expression of NF-κB-regulated drug-resistant genes

Paclitaxel (or Taxol(®)) is a first-line chemotherapeutic drug for the treatment of non-small cell lung cancer; however, resistance to the drug is an important factor, which influences the outcome of chemotherapy. The present study aimed to investigate the role of triptolide (TPL) in reversing Taxol...

Descripción completa

Detalles Bibliográficos
Autores principales:	JIANG, NING, DONG, XIAO-PENG, ZHANG, SUO-LIN, YOU, QING-YONG, JIANG, XING-TAO, ZHAO, XIAO-GANG
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4686042/ https://www.ncbi.nlm.nih.gov/pubmed/26531258 http://dx.doi.org/10.3892/mmr.2015.4493

Ejemplares similares

A new perspective of triptolide-associated hepatotoxicity: the relevance of NF-κB and NF-κB-mediated cellular FLICE-inhibitory protein
por: Yuan, Ziqiao, et al.
Publicado: (2020)

Triptolide attenuates proteinuria and podocyte apoptosis via inhibition of NF-κB/GADD45B
por: Wang, Ling, et al.
Publicado: (2018)

Triptolide Transcriptionally Represses HER2 in Ovarian Cancer Cells by Targeting NF-κB
por: Ou, Chien-Chih, et al.
Publicado: (2012)

Triptolide Combined with Radiotherapy for the Treatment of Nasopharyngeal Carcinoma via NF-κB-Related Mechanism
por: Zhang, Weiying, et al.
Publicado: (2016)

The Antigastric Cancer Effect of Triptolide is Associated With H19/NF-κB/FLIP Axis
por: Yuan, Weiwei, et al.
Publicado: (2022)

Triptolide reverses hypoxia-induced epithelial–mesenchymal transition and stem-like features in pancreatic cancer by NF-κB downregulation
por: Liu, Li, et al.
Publicado: (2014)

RelB/NF-κB links cell cycle transition and apoptosis to endometrioid adenocarcinoma tumorigenesis
por: Ge, Qiu-Lin, et al.
Publicado: (2016)

Fatostatin reverses progesterone resistance by inhibiting the SREBP1-NF-κB pathway in endometrial carcinoma
por: Ma, Xiaohong, et al.
Publicado: (2021)

NFκB and Kidney Injury
por: Song, Ning, et al.
Publicado: (2019)

OXCT1 Enhances Gemcitabine Resistance Through NF-κB Pathway in Pancreatic Ductal Adenocarcinoma
por: Ding, Jinsheng, et al.
Publicado: (2021)

Ivermectin reverses the drug resistance in cancer cells through EGFR/ERK/Akt/NF-κB pathway
por: Jiang, Lu, et al.
Publicado: (2019)

NF-κB and Disease
por: Poma, Paola
Publicado: (2020)

Immunosuppression through constitutively activated NF-κB signalling in human ovarian cancer and its reversal by an NF-κB inhibitor
por: Nishio, H, et al.
Publicado: (2014)

Triptolide attenuates lipopolysaccharide-induced inflammatory responses in human endothelial cells: involvement of NF-κB pathway
por: Song, Chundong, et al.
Publicado: (2019)

NF-κB Members Left Home: NF-κB-Independent Roles in Cancer
por: Colomer, Carlota, et al.
Publicado: (2017)

Cajanol Sensitizes A2780/Taxol Cells to Paclitaxel by Inhibiting the PI3K/Akt/NF-κB Signaling Pathway
por: Sui, Ming, et al.
Publicado: (2021)

Association between NF-κB expression and drug resistance of liver cancer
por: Liu, Tao, et al.
Publicado: (2019)

Effects of triptolide from Radix Tripterygium wilfordii (Leigongteng) on cartilage cytokines and transcription factor NF-κB: a study on induced arthritis in rats
por: Xiao, Cheng, et al.
Publicado: (2009)

NF-κB and the Immunoglobulin κ Gene Enhancer
por: Sen, Ranjan
Publicado: (2004)

Analysis of variation in NF-κB genes and expression levels of NF-κB-regulated molecules
por: Liu-Mares, Wen, et al.
Publicado: (2007)

NF-κB-Mediated Regulation of Osteoclastogenesis
por: Boyce, Brendan F., et al.
Publicado: (2015)

The interaction between ER and NFκB in resistance to endocrine therapy
por: Sas, Leen, et al.
Publicado: (2012)

Triptolide Inhibits Invasion and Tumorigenesis of Hepatocellular Carcinoma MHCC-97H Cells Through NF-κB Signaling
por: Wang, Haiji, et al.
Publicado: (2016)

Neuroprotection by triptolide against cerebral ischemia/reperfusion injury through the inhibition of NF-κB/PUMA signal in rats
por: Zhang, Bin, et al.
Publicado: (2016)

Triptolide ameliorates fine particulate matter-induced podocytes injury via regulating NF-κB signaling pathway
por: Wan, Qiang, et al.
Publicado: (2020)

NF‐κB signaling in inflammation and cancer
por: Zhang, Tao, et al.
Publicado: (2021)

NF-κB fingerprinting reveals heterogeneous NF-κB composition in diffuse large B-cell lymphoma
por: Jayawant, Eleanor, et al.
Publicado: (2023)

Keeping NF-κB in check
por: Williams, Ruth
Publicado: (2006)

At the crossroads of SUMO and NF-κB
por: Kracklauer, Martin P, et al.
Publicado: (2003)

Slow but steady for NF-κB
por: Leslie, Mitch
Publicado: (2012)

NF-κB in premature aging
por: Osorio, Fernando G., et al.
Publicado: (2012)

Hypoxia Induced NF-κB
por: D’Ignazio, Laura, et al.
Publicado: (2016)

NF-κB signaling in inflammation
por: Liu, Ting, et al.
Publicado: (2017)

Noncanonical NF-κB in Cancer
por: Tegowski, Matthew, et al.
Publicado: (2018)

NF-κB in Hematological Malignancies
por: Imbert, Véronique, et al.
Publicado: (2017)

NF-κB Signalling in Glioblastoma
por: Soubannier, Vincent, et al.
Publicado: (2017)

TXNIP/TRX/NF-κB and MAPK/NF-κB pathways involved in the cardiotoxicity induced by Venenum Bufonis in rats
por: Bi, Qi-rui, et al.
Publicado: (2016)

To NFκB or not to NFκB: The Dilemma on How to Inhibit a Cancer Cell Fate Regulator
por: Sorriento, Daniela, et al.
Publicado: (2012)

Shenlian Extract Against Myocardial Injury Induced by Ischemia Through the Regulation of NF-κB/IκB Signaling Axis
por: Guo, Yuan, et al.
Publicado: (2020)

NF-κB Mutations in Germinal Center B-Cell Lymphomas: Relation to NF-κB Function in Normal B Cells
por: Pasqualucci, Laura, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e8htkf04msgfd4pq2s5mlcn8fv